City Trees Announces New Market Venture in New Mexico Through Licensing Agreement.
LAS VEGAS, NV / ACCESSWIRE / November 15, 2023 / CLS Holdings USA, Inc. (OTCQB:CLSH)(CSE:CLSH), (the ''Company'' or ''CLS''), a...
Month: November 2023
CNS Pharmaceuticals Reports Third Quarter 2023 Financial Results and Reiterates Company is on Track to Achieve Milestones for Berubicin Potentially Pivotal Study Before Year End
- Enrollment numbers rise to 239 in ongoing potentially pivotal study of Berubicin for treatment of GBM; Expected full enrollment...
StageZero Life Sciences, Ltd Announces Q3 2023 Financial Results and Operational Update
TORONTO, ON / ACCESSWIRE / November 15, 2023 / StageZero Life Sciences ("StageZero" or the "Company") (TSX:SZLS), an integrated healthcare...
Envision Pharma Group Announces New AI Innovation Board and Appoints Chairwoman
The new board and leadership appointment aligns with the company's commitment to advancing the industry through innovation and the expansion...
NanoViricides Has Filed its Quarterly Report – NV-387 Broad-Spectrum Antiviral in Clinical Trials Has Additional Applications
SHELTON, CT / ACCESSWIRE / November 15, 2023 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), reports that it has filed...
PharmAla Biotech and Filament Health Announce Release of Second Batch of GMP MDMA Capsules
Filament Health and PharmAla Biotech also completed shipments to a number of Australian clientsVANCOUVER, British Columbia, Nov. 15, 2023 (GLOBE...
USDA-APHIS Determines that Yield10 Bioscience’s Stacked Herbicide Tolerant Camelina May Be Planted and Bred in the United States
-Herbicide Technology Critical to Enabling Large-Acreage Adoption of Camelina in North AmericaWOBURN, Mass., Nov. 15, 2023 (GLOBE NEWSWIRE) -- Yield10 Bioscience,...
USDA-APHIS Determines that Yield10 Bioscience’s Glufosinate Tolerant Camelina May Be Planted and Bred in the United States
-Yield10 Achieves a Significant Milestone in the Development of Camelina as a Commercial Crop for Producing Biofuels and Omega-3 Oils -On...
Shockwave Medical to Participate in the Piper Sandler 35th Annual Healthcare Conference
SANTA CLARA, Calif., Nov. 15, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and...
Carmot Therapeutics Commenced Phase 2 Clinical Trial of Novel Dual GLP-1/GIP Receptor Agonist CT-868 for the Treatment of Type 1 Diabetes
– Randomized, placebo-controlled trial to assess 16-week treatment with CT-868 in participants with overweight or obesity with type 1 diabetes...
Awakn Life Sciences Receives Regulatory and Ethical Approval for Phase III Clinical Trial of AWKN-P001
AWKN-P001 is a N-methyl-D-aspartate Receptor-Modulating Drug Used in Combination with Psycho-Social Support for the Treatment of Severe Alcohol Use DisorderToronto,...
FendX Provides Corporate Update
Oakville, Ontario--(Newsfile Corp. - November 15, 2023) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the "Company" or...
BioNxt Reports on New Cladrabine ODF Product Development and Commercialization Program
VANCOUVER, BC / ACCESSWIRE / November 15, 2023 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT) is pleased to...
CBD of Denver Inc. Announces Major Retail Expansion with EDEKA, Introduces Innovative Anti-Slip Installation
Denver, Colorado--(Newsfile Corp. - November 15, 2023) - CBD of Denver, Inc. (OTC Pink: CBDD), today announced that EDEKA's Southwest...
Planet 13 Enters into Settlement Agreement
LAS VEGAS, NV / ACCESSWIRE / November 14, 2023 / Planet 13 Holdings Inc. (CSE:PLTH)(OTCQX:PLNH) ("Planet 13" or the "Company"),...
Scientific Industries Reports Financial Results for Third Quarter 2023
Bioprocessing Operations Launched Revolutionary New ProductsBioprocessing Revenue Generated From Legacy Products Up 36%Vivid Pill Counters YTD Revenue Up 75%BOHEMIA, NY...
Charlie’s Holdings Makes Significant Progress on SPREE BAR(TM) and Greatly Reduces Expenses for the Third Quarter Ended September 30, 2023
SPREE BAR Master Distributor Agreements Signed, Purchase Orders and Cash Deposits ReceivedCOSTA MESA, CA / ACCESSWIRE / November 14, 2023...
Elite Pharmaceuticals, Inc. Reports Financial Results for Second Quarter of Fiscal Year 2024 ended September 30, 2023 and Provides Conference Call Information
Conference Call Scheduled for Wednesday, November 15 at 11:30 AM ESTNORTHVALE, NJ / ACCESSWIRE / November 14, 2023 / Elite...
Biotricity Delivers Record Margins and Double Digit Year-Over-Year Sales Growth for Second Quarter of Fiscal Year 2024
Company reports Q2-FY24 revenue grew by 21.4% YOY to $2.9 million; continuing to advance toward positive cashflowRecurring technology fees, customer...
Aytu BioPharma Reports Fiscal 2024 First Quarter Financial Results
Q1 2024 Adjusted EBITDA of $2.2 millionRx Segment net revenue of $17.8 million and Adjusted EBITDA of $2.4 million in...